THIS WEBSITE IS FOR BUSINESS & INDUSTRY PARTNERS. FOR CONSUMER PRODUCTS VISIT : BLIS Probiotics >
The latest updates on our probiotic developments and news.
Oral health is often thought of as simply looking after your teeth and gums, but new research has uncovered the bi-directional relationship between the oral microbiome and systemic disease.
One of the most common and painful side effects of cancer treatment is mouth sores, medical known as oral mucositis, affecting a significant percentage of patients undergoing chemotherapy and radiotherapy. Recent studies have highlighted the potential of BLIS K12™ in providing much-needed relief for this condition.
We’re partnering with the IPA World Congress + Probiota Americas this June. Join us in Salt Lake City to dive into the world of microbiome science and business.
In our latest whitepaper, a recent study shows that BLIS K12™ stimulates the production of antibodies specific to SARS CoV-2 virus in people that have been vaccinated for COVID-19 and led to accelerated viral clearance.
Otitis media, a term that may sound unfamiliar to many, refers to a common condition that affects the middle ear. This inflammation can occur in people of all ages but is particularly prevalent in children.
The recent scientific breakthroughs in understanding the interplay between the immune system, the oral microbiota, and the SARS-CoV-2 virus have paved the way for exciting revelations in the field of probiotics.
Pregnancy is a time of immense change in a woman’s body. The immune system undergoes significant alterations during pregnancy, and expecting mothers
Rosacea is a chronic skin condition that affects millions worldwide, characterized by facial redness, visible blood vessels, swelling, and sometimes, acne-like breakouts.
In our latest whitepaper, shows BLIS M18™ significantly reduces gingivitis in young adults and improved dental health in pre-schoolers that had dental caries, reducing them by 81%.
Halitosis, commonly known as bad breath, can be a persistent and embarrassing problem affecting millions worldwide, with the halitosis treatment market size valued at USD 10.93 billion in 2021…
Halitosis (bad breath) can be a major source of embarrassment and social anxiety for some people. Bad breath is estimated to affect half the adult population at some time, to some extent. BLIS K12™ has been scientifically proven to inhibit bacteria that cause halitosis…
Frequent illnesses among children can disrupt education, impact work schedules, and strain family harmony. explore the benefits of BLIS K12™ as a dietary supplement that supports kids’ immunity and fighting cold and flu.
